Skip to main content

MSF welcomes GSK decision

MSF welcomes GSK decision

MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children.

On September 20th, 2016 Médecins Sans Frontiéres/Doctors without Borders (MSF) welcomed the decision by GlaxoSmithKline (GSK) to lower its price of its pneumococcal conjugate vaccine (PCV) for humanitarian organizations that serve refugee and crisis-affected children.

Read on for the entire announcement .